Benefit of COLARIS® Testing

The results of the COLARIS® test enable the development of a patient-specific medical management roadmap to significantly reduce the risk of cancer.  COLARIS will help you to:

  • Target increased surveillance and other interventions specifically to individuals with a Lynch syndrome or MYH-associated polyposis mutation(s)€”maximizing patient care and increasing clinical efficiency
  • Improve patient compliance with tailored screening recommendations and preventive measures
  • Significantly improve outcomes and reduce medical costs through prevention, earlier diagnosis and treatment of cancer, should it develop
  • Counsel patients and family members on the underlying cause of cancer in their family
  • Avoid unnecessary interventions for family members who do not test positive for the mutation(s) known to be in the family

Medical Management Strategies that May Reduce the Risk of Cancer

benefit_colaris